| Offering Information |
| Expected Date | WITHDRAWN |
| Proposed Exchange/Ticker |
Nasdaq: GMSI |
| Security Type |
Class A Common Shares |
| Lead Underwriter |
ABN AMRO Incorporated |
| Days In Registration |
372 |
| Date Filed |
30-Jul-1998 |
| Form Filed | S-1 |
Fundamentals
(Year Ending December 2007) |
| Industry |
Pers/Bus/Rep Svc |
| Business Description |
Provides sterilization mangagement services including processing and related lab testing, consulting, and logistics management. |
| Revenue |
- |
| Net Income |
- |
| Shares Outstanding (post-offering) |
- |
| President and CEO |
Kevin M. Swan |
| Number of Employees |
483 |
|
| Original Filing Information |
| US |
| Shares Filed |
2.5M |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
- |
| · As a Percent |
- |
| Overallotment Shares Filed |
375.0K |
| File Amount |
- |
| File Price Range |
$15.00 - $13.00 |
| File Mid Price |
$14.00 |
|
